000 | 01972 a2200565 4500 | ||
---|---|---|---|
005 | 20250517001916.0 | ||
264 | 0 | _c20150511 | |
008 | 201505s 0 0 eng d | ||
022 | _a1546-0096 | ||
024 | 7 |
_a10.1186/1546-0096-12-47 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPagnini, Ilaria | |
245 | 0 | 0 |
_aBone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. _h[electronic resource] |
260 |
_bPediatric rheumatology online journal _c2014 |
||
300 |
_a47 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAutoimmune Diseases _xdrug therapy |
650 | 0 | 4 |
_aBone Resorption _xdiagnostic imaging |
650 | 0 | 4 |
_aBone and Bones _xdiagnostic imaging |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aConnective Tissue Diseases _xdrug therapy |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPrednisone _xadverse effects |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPregnancy Complications _xdrug therapy |
650 | 0 | 4 |
_aPrenatal Exposure Delayed Effects _xdiagnostic imaging |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aUltrasonography |
700 | 1 | _aSimonini, Gabriele | |
700 | 1 | _aCavalli, Loredana | |
700 | 1 | _ala Marca, Giancarlo | |
700 | 1 | _aIuliano, Annamaria | |
700 | 1 | _aBrandi, Maria Luisa | |
700 | 1 | _aBellisai, Francesca | |
700 | 1 | _aFrediani, Bruno | |
700 | 1 | _aGaleazzi, Mauro | |
700 | 1 | _aCantarini, Luca | |
700 | 1 | _aCimaz, Rolando | |
773 | 0 |
_tPediatric rheumatology online journal _gvol. 12 _gp. 47 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1546-0096-12-47 _zAvailable from publisher's website |
999 |
_c24330421 _d24330421 |